# Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease

> **NCT04697888** · PHASE2,PHASE3 · COMPLETED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 2 (actual)

## Conditions studied

- Parenteral Nutrition-related Hepatitis

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT04697888
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04697888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04697888, "Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04697888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*